Today APOP ranks # as SELL CANDIDATE.
Today APOP ranks # as SELL CANDIDATE.

APOP stock Cellect Biotechnology Ltd

APOP stock
Cellect Biotechnology Ltd

April 18, 2019
Change 1.70%
Chart period: 2019-01-22 - 2019-04-18
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Sell

Will APOP stock price go up or down on Mon, 22 Apr 2019?

Cellect Biotechnology Ltd Forecast and Stock Analysis

Technical APOP stock analysis for April 18, 2019.

Sell candidate since 2019-04-09 Loss -9.56%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.36
ROA -77.47

Cellect Biotechnology Ltd gained 1.70% in the last trading day, rising from $0.88 to $0.89 The price has fallen in 6 of the last 10 days and is down by -8.3% for this period. Volume fell in the last day by -137 854 shares, and in total, 56 247 shares bought and sold for approximately $50 054.20. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Thursday, 18th Apr 2019) of the APOP stock was $0.89. This is 1.7% more than the trading day before Wednesday, 17th Apr 2019.

During day the stock fluctuated 8.05% from a day low at $0.85 to a day high of $0.92.

30 day high of the APOP stock price was $1.11 and low was $0.85.
90 day high was $3.83 and low was $0.85.
52 week high for the Cellect Biotechnology Ltd - $7.80 and low - $0.85.

Trend

Cellect Biotechnology Ltd lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -51.80% during the next 3 months and, with 90% probability hold a price between $-0.03 and $0.68 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Wednesday April 17, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Cellect Biotechnology Ltd holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.93 and $1.00. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 28 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Cellect Biotechnology Ltd finds support from accumulated volume at $0.88.

Support: $0.88 Price: $0.89 Resistance: $0.99

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.07 between high and low, or 8.05%. For the last week the stock has had a daily average volatility of 8.40%.

Cellect Biotechnology Ltd is oversold on RSI14 (28). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation: Sell Candidate

Cellect Biotechnology Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Today APOP ranks # as SELL CANDIDATE.
Today APOP ranks # as SELL CANDIDATE.